Stock vs Stock Comparison

Jacobs Solutions Inc. vs Arcosa, Inc.

ACA wins the Tale of the Tape 5–4.

J$121.28
ACA

🏆 Tale of the Tape

45
JACA
2.4%Profitability (Net Margin)7.2%
35.4xValuation (P/E)28.3x
6.9%Efficiency (ROIC)6.2%
7/9Health (Piotroski F)8/9
2.9Safety (Altman Z)
4.6%Growth (Rev YoY)12.2%
0.24Risk (Sharpe 1Y)
1.41xBalance Sheet (D/E)0.89x
3.92%FCF Yield

Green = winner in each category. Higher is better except P/E (lower = cheaper).

Fundamentals

MetricJACA
Market Cap$14.2B$5.9B
P/E Ratio35.4x28.3x
Forward P/E14.5x22.4x
P/B4.30x2.23x
Dividend Yield1.20%0.17%
Beta0.710.96

Quantitative Metrics

MetricJACA
DCF Fair Value$213.63$99.96
DCF Upside+70.5%
Piotroski F7/98/9
Altman Z2.89
Beneish M-2.58-2.48
FCF Yield3.92%
Net Debt/EBITDA1.1x2.3x
ROIC6.9%6.2%
WACC8.8%
ROIC – WACC-1.9pp
Gross Margin24.8%22.4%
Net Margin2.4%7.2%
Rev Growth YoY4.6%12.2%
Sharpe (1Y)0.24
Max Drawdown 3Y
FCF Payout Ratio25%6%

J Price

Loading chart...

ACA Price

Loading chart...

ETF Exposure

J found in:

VBR0.34%
ONEV0.31%
XLI0.25%
VIS0.22%
RSP0.20%
VB0.19%
VFQY0.13%
ONEO0.09%
SCHV0.06%
VONV0.05%
IWD0.05%
SPYV0.05%
SPLG0.03%
IVV0.03%
SCHX0.03%
SCHB0.02%
ITOT0.02%
SPTM0.02%
SPY0.02%
URTH0.02%
VONE0.02%
VTI0.02%
VOO0.02%
ACWI0.02%
QUS0.01%

ACA found in:

SLYG0.45%
SPSM0.35%
SLYV0.25%
VTWO0.18%
VFMO0.15%
VBR0.14%
VGK0.12%
VYMI0.10%
VIS0.09%
SPDW0.08%
VB0.08%
VXF0.08%
VEA0.06%
VSGX0.06%
CWI0.05%
VEU0.05%
VXUS0.04%
SPTM0.01%

More Comparisons

Quant metrics computed from financial statements and 1,200+ trading days. Correlation is Pearson coefficient on daily log returns. Not investment advice.

J vs ACA: Head-to-Head Analysis

Jacobs Solutions Inc. (J) and Arcosa, Inc. (ACA) represent two companies in the Industrials sector. In our quantitative Tale of the Tape scoring, ACA leads 5–4 across nine fundamental and risk metrics including profitability, valuation, capital efficiency, and financial health.

In terms of capital efficiency, J generates a return on invested capital (ROIC) of 6.9% compared to ACA's 6.2%. This suggests J is more effective at deploying capital to generate shareholder returns.

J appears in 25 ETFs tracked by SecuritiesDB, while ACA appears in 18 ETFs. Investors holding broad-market ETFs may already have indirect exposure to both stocks.

Frequently Asked Questions

Which stock is the better investment, J or ACA?

Our quantitative analysis compares J and ACA across nine fundamental dimensions. ACA wins the Tale of the Tape 5–4. However, stock selection depends on your individual risk tolerance, time horizon, and portfolio context. These metrics are computed from SEC filings and market data — they are not investment recommendations.

Are J and ACA correlated?

Correlation data is not yet available for this pair. Check back after both stocks have sufficient trading history.

How is the Tale of the Tape scored?

The Tale of the Tape compares both stocks across nine categories: profitability (net margin), valuation (P/E), efficiency (ROIC), health (Piotroski F-Score), safety (Altman Z-Score), growth (revenue YoY), risk (Sharpe ratio), leverage (debt-to-equity), and cash generation (FCF yield). The stock that wins more categories takes the overall score. Lower P/E and lower debt-to-equity count as wins.